Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenshenyang decoction is a traditional Chinese herbal formula composed mainly of three herbs: Cistanche deserticola, Epimedium sagittatum, and Drynaria roosii[2][5]. It is designed to "tonify kidney yang" according to traditional Chinese medicine theory and is used primarily for chronic kidney disease, especially in patients with kidney yang deficiency[1][2][5]. Integrated metabolomics and network pharmacology analyses have shown that the core active components are quercetin, luteolin, and kaempferol, acting principally via modulation of linoleic acid metabolism, FcεRI signaling, unsaturated fatty acid biosynthesis, and multiple gene targets (PTGS2, AKT1, MMP9, EGFR, MMP2, ANGPTL4, FGFR1, SIRT3, glucocorticoid receptor)[2][5]. Preclinical and clinical studies indicate efficacy in improving renal function and alleviating CKD symptoms, with a mechanism involving multi-target regulation including anti-inflammatory, antioxidant, and cell-protective effects[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wenshenyang decoction.